Company Profile
Indaptus Therapeutics Stock Price, News & Analysis
- Ticker:
- INDP
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Indaptus Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
3.71 USD (-1.72%)
Close
Last updated: June 23, 2026 at 00:00
420.13M USD
Market cap
Why the stock is moving
INDP is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Indaptus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Indaptus Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Indaptus Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Indaptus Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Indaptus Therapeutics (INDP)?
Indaptus Therapeutics (INDP) most recently closed at 3.71 USD, a -1.72% move versus the previous session.
What is the market cap of Indaptus Therapeutics (INDP)?
Indaptus Therapeutics currently has a market capitalization of 420.13M USD on BioPharmSignal.
What does Indaptus Therapeutics do?
Indaptus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is INDP stock listed?
Indaptus Therapeutics (INDP) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Indaptus Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Indaptus?
Indaptus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Indaptus Therapeutics targeting with Indaptus?
Indaptus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Indaptus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.